MedTrace Logo

Clinical Study to Evaluate the Anti-adhesion Efficacy and Safety of MegaShield®-SP in Comparison With Guardix-SP Plus After Spine Surgery

NCT06369233 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-03-04

No results posted yet for this study

Summary

This study is Interventional, Parallel, Double-blinded, Randomized study. Subjects aged 20 to 70 years who had a Lumbar discectomy or laminectomy, MegaShield-SP® and Guardix-SP Plus will be applied.

Conditions

  • Herniation, Disc

Interventions

DEVICE

MegaShield®-SP

MegaShield®-SP application Lumbar discectomy or laminectomy

DEVICE

Guardix-SP Plus

Guardix-SP Plus application Lumbar discectomy or laminectomy

Sponsors & Collaborators

  • L&C Bio

    lead INDUSTRY

Principal Investigators

  • Siyoung Park · Yonsei University College of Medicine, Severance Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2026-05-31
Completion
2026-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06369233 on ClinicalTrials.gov